A randomised phase III study of bevacizumab and carboplatin–pemetrexed chemotherapy with or without atezolizumab as first-line treatment for advanced pleural mesothelioma: results of the ETOP 13-18 BEAT-meso trial
Titel:
A randomised phase III study of bevacizumab and carboplatin–pemetrexed chemotherapy with or without atezolizumab as first-line treatment for advanced pleural mesothelioma: results of the ETOP 13-18 BEAT-meso trial
Auteur:
Felip, E. Popat, S. Dafni, U. Ribi, K. Pope, A. Cedres, S. Shah, R. de Marinis, F. Cove Smith, L. Bernabé, R. Früh, M. Nackaerts, K. Greillier, L. Scherz, A. Massuti, B. Nadal, E. Vila Martinez, L. Talbot, T. Roschitzki-Voser, H. Dimopoulou, G. Schär, S. Ruepp, B. Savic, S. Peters, S. Stahel, R.